CVS Health plans to split itself up. Here's why a breakup could make sense now

Summary

• CVS Health announced plans to split into two publicly traded companies by the first half of 2028.
• The retail pharmacy business, including roughly 9,000 locations, will separate from the insurance & pharmacy benefit manager unit, Caremark.
• Aetna, Caremark, specialty pharmacy, Oak Street Health, & Signify Health will remain together in the healthcare company.
• The retail pharmacy company will include the 9,000 stores, mail pharmacy operations, & MinuteClinic.
• CVS posted eight consecutive quarters of beating Wall Street earnings estimates & raised guidance multiple times over the last two years.
• The company expects to generate at least $15.5 billion in operating cash flow in 2026, a 70% increase from 2024.
• CVS has reached its leverage target ahead of schedule following a turnaround plan involving $2 billion in cost cuts & store closures.
• CVS shares dropped about 12% following the announcement despite investor cheers for recent financial progress.
• Retail pharmacy margins remain low at roughly 4% to 5%, but the business has become more consistently profitable.
• CVS gained market share as competitors like Walgreens & Rite Aid closed stores & reduced their footprints.
• The CostVantage program replaced traditional reimbursement with a transparent, cost-based model to align payments with dispensing costs.
• Aetna improved performance by exiting unprofitable markets, expanding value-based care, & tightening utilization management.
• Caremark faces state-level legal challenges in Tennessee & Arkansas that ban single companies from owning both a pharmacy & a PBM.
• CVS CEO David Joyner stated the split is a strategic decision made out of strength rather than due to regulatory pressure.
• The company intends to preserve commercial relationships between the split entities through agreements over the next 15 to 18 months.
• Analysts question whether future contracts will maintain the same competitive advantages & flexibility as under common ownership.
• Retail pharmacy growth faces risks from consumer pressure & competition from online pharmacies.
• Caremark faces potential headwinds from changes to the federal 340B drug discount program & regulatory scrutiny.
• Aetna continues a multiyear plan to rebuild margins & improve profitability in its Medicare Advantage business.